Investor Centre
Shareholder Information
Company overview
Microba Life Sciences (ASX:MAP) is a precision microbiome company driven to improve human health. With world-leading technology for measuring the human gut microbiome, Microba is driving the discovery and development of novel therapeutics for major chronic diseases and delivering gut microbiome testing services globally to researchers, clinicians, and consumers. Through partnerships with leading organisations, Microba is powering the discovery of new relationships between the microbiome, health and disease for the development of new health solutions.
Shareholder information
Share Price
Please refer to the ASX website for further information.
Listing
Australian Securities Exchange
ASX Code: MAP
Registered Office
Level 10, 324 Queen St
Brisbane, QLD 4000
Telephone: +61 1300 974 621
Fax +61 1300 974 621
Directors
Pasquale Rombola – Chairman
Professor Ian Hector Frazer – Deputy Chairman
Dr Caroline Popper – Non-Executive Director
Richard Bund – Non-Executive Director
Professor Gene Tyson – Non-Executive Director
Dr Hyungtae Kim – Non-Executive Director
Senior management
Dr Luke Reid – Chief Executive Officer
James Heath – Chief Financial Officer, Company Secretary
Peter Webse – Joint Co. Secretary
Investor enquiries
Investor Relations
investor@microba.com
Media Relations
Simon Hinsley
Investor / Media Relations
simon@nwrcommunications.com.au